| scholarly article | Q13442814 |
| P2093 | author name string | Paul S Charifson | |
| Trudy H Grossman | |||
| Stephen P Chambers | |||
| William Markland | |||
| Martyn Botfield | |||
| Maureen Dwyer | |||
| Christian H Gross | |||
| Jonathan D Parsons | |||
| Steven Bellon | |||
| Scott A Raybuck | |||
| James Jernee | |||
| P2860 | cites work | A model for the mechanism of strand passage by DNA gyrase | Q24675025 |
| Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center | Q27621859 | ||
| The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study | Q27741104 | ||
| Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage | Q32124532 | ||
| Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance | Q33982709 | ||
| Resistance to antibiotics mediated by target alterations | Q34339223 | ||
| Crystal structure of an N-terminal fragment of the DNA gyrase B protein. | Q34493198 | ||
| Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase | Q35042255 | ||
| Energy coupling in DNA gyrase and the mechanism of action of novobiocin | Q35994466 | ||
| gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi | Q36107774 | ||
| DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy | Q36115385 | ||
| Identifying the catalytic residue of the ATPase reaction of DNA gyrase | Q36697175 | ||
| Isolation and characterization of Bacillus subtilis genes involved in siderophore biosynthesis: relationship between B. subtilis sfpo and Escherichia coli entD genes | Q36773698 | ||
| Conversion of DNA gyrase into a conventional type II topoisomerase | Q37039334 | ||
| An unusual mechanism for resistance to the antibiotic coumermycin A1 | Q37603477 | ||
| Mutations in the B subunit of Escherichia coli DNA gyrase that affect ATP-dependent reactions | Q38358833 | ||
| Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region | Q39478070 | ||
| Isolation and characterisation of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K12 | Q39588522 | ||
| Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase | Q39718513 | ||
| GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin. | Q39781947 | ||
| Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance | Q39837651 | ||
| Mutations in DNA gyrase result in novobiocin resistance in halophilic archaebacteria | Q39938412 | ||
| Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting | Q40399549 | ||
| DNA gyrase action involves the introduction of transient double-strand breaks into DNA | Q40602513 | ||
| Inactivation of antibiotics and the dissemination of resistance genes | Q40737331 | ||
| Prevention of drug access to bacterial targets: permeability barriers and active efflux | Q40737334 | ||
| DNA gyrase as a drug target | Q40902870 | ||
| The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography | Q41064279 | ||
| A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase | Q42029877 | ||
| Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase | Q47870352 | ||
| The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. | Q52399144 | ||
| Timely release of both replication forks from oriC requires modulation of origin topology. | Q52933818 | ||
| Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis. | Q53921739 | ||
| Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking. | Q53923658 | ||
| Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance. | Q54127765 | ||
| gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. | Q54269895 | ||
| Probing the Binding of Coumarins and Cyclothialidines to DNA Gyrase† | Q57980003 | ||
| Hydrolysis of ATP at Only One GyrB Subunit Is Sufficient to Promote Supercoiling by DNA Gyrase | Q57980006 | ||
| The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription 1 1J. Karn | Q59695031 | ||
| Exploiting Nucleotide Thiophosphates To Probe Mechanistic Aspects ofEscherichia coliDNA Gyrase† | Q59695033 | ||
| The Interaction of Coumarin Antibiotics with Fragments of the DNA Gyrase B Protein† | Q59695045 | ||
| The DNA dependence of the ATPase activity of DNA gyrase | Q59695110 | ||
| Coumermycin A1: A preferential inhibitor of replicative DNA synthesis in Escherichia coli. I. In vivo characterization | Q67487230 | ||
| The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases | Q67505712 | ||
| Regulation of the genes for E. coli DNA gyrase: Homeostatic control of DNA supercoiling | Q70157448 | ||
| DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism | Q72428717 | ||
| Mechanisms of fluoroquinolone resistance | Q74371163 | ||
| Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability | Q74386329 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1037-1046 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance | |
| P478 | volume | 47 |
| Q36769094 | 3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors |
| Q33796345 | A high-throughput fluorescence polarization assay for inhibitors of gyrase B |
| Q24567584 | Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase |
| Q43111811 | DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties |
| Q45059162 | DNA gyrase is involved in chloroplast nucleoid partitioning. |
| Q41822811 | Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds |
| Q64941577 | Effects of Lysozyme on the Activity of Ionic of Fluoroquinolone Species. |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q37694351 | In front of and behind the replication fork: bacterial type IIA topoisomerases. |
| Q34510396 | In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class |
| Q21146381 | Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species |
| Q37519599 | Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance |
| Q27685473 | Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion |
| Q36158288 | Protective effect of Qnr on agents other than quinolones that target DNA gyrase |
| Q33584190 | Real-time visualization of photochemically induced fluorescence of 8-halogenated quinolones: lomefloxacin, clinafloxacin and Bay3118 in live human HaCaT keratinocytes |
| Q39492541 | SiO2@Fe2O3 core-shell nanoparticles for covalent immobilization and release of sparfloxacin drug. |
| Q45752554 | Silver(I) complexes as precursors to produce silver nanowires: structure characterization, antimicrobial activity and cell viability |
| Q39117573 | The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). |
| Q55227172 | Why Two? On the Role of (A-)Symmetry in Negative Supercoiling of DNA by Gyrase. |
Search more.